AQP4 and systemic lupus erythematosus: Special consideration should also be given to anti-aquaporin 4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies, as they may occur in a subset of SLE patients and could relate to demyelinating forms (see Section 3.9).